Skip to main content
logo
Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.780
+0.020 (1.14%)
At close: Oct 30, 2025, 4:00 PM EDT
1.700
-0.080 (-4.49%)
Pre-market: Oct 31, 2025, 4:56 AM EDT

Ernexa Therapeutics Revenue

Ernexa Therapeutics had revenue of $488.00K in the twelve months ending June 30, 2025, up 201.23% year-over-year. In the year 2024, Ernexa Therapeutics had annual revenue of $582.00K with 755.88% growth.

Revenue (ttm)
$488.00K
Revenue Growth
+201.23%
P/S Ratio
10.59
Revenue / Employee
$81,333
Employees
6
Market Cap
13.65M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024582.00K514.00K755.88%
Dec 31, 202368.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

ERNA News

More News